ArticleHealth science reports2025

Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Laiba Shakeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.